Risk of high‐grade malignancy in parotid gland tumors as classified by the Milan System for Reporting Salivary Gland Cytopathology

2019 ◽  
Vol 48 (3) ◽  
pp. 222-231 ◽  
Author(s):  
Woori Park ◽  
Hyunsik Bae ◽  
Min‐Hae Park ◽  
Na Young Hwang ◽  
Insuk Sohn ◽  
...  
Keyword(s):  
Salivary Gland ◽  
Parotid Gland ◽  
High Grade ◽  
Parotid Gland Tumors ◽  
Grade Malignancy ◽  
High Grade Malignancy

EGFR, HER2, survivin, and loss of pSTAT3 characterize high-grade malignancy in salivary gland cancer with impact on prognosis

2012 ◽  
Vol 43 (6) ◽  
pp. 921-931 ◽  
Author(s):  
Tobias Ettl ◽  
Clemens Stiegler ◽  
Katharina Zeitler ◽  
Abbas Agaimy ◽  
Johannes Zenk ◽  
...  
Keyword(s):  
Salivary Gland ◽  
Salivary Gland Cancer ◽  
High Grade ◽  
Grade Malignancy ◽  
High Grade Malignancy

Primary Malignant Lymphoma of the Salivary Glands

1986 ◽  
Vol 72 (5) ◽  
pp. 491-497 ◽  
Author(s):  
Lisbet Hjorth ◽  
Hans Dommerby ◽  
Steen Kruse ◽  
Annemarie Nielsen
Keyword(s):  
Parotid Gland ◽  
Malignant Lymphoma ◽  
Salivary Glands ◽  
Low Grade ◽  
High Grade ◽  
Malignant Lymphomas ◽  
Localized Disease ◽  
Grade Malignancy ◽  
Disseminated Disease ◽  
High Grade Malignancy

Five cases of primary malignant lymphomas of the salivary glands are reported. Four lymphomas arose in the parotid gland and one in the submandibular gland. All were non-Hodgkin lymphomas. In 4 cases the lymphomas were of low-grade malignancy, viz. 2 immunocytomas and 2 centroblastic/centrocytic malignant lymphomas, and 1 was a T-immunoblastic malignant lymphoma of high-grade malignancy. Four patients with localized disease were treated with radiotherapy and 1 patient with disseminated disease was treated with chemotherapy. One patient died from a disease unrelated to the malignant lymphoma, and 4 patients were alive at 66-136 months after treatment.

Low-grade malignant perineurioma of the paravertebral column, transforming into a high-grade malignancy

1999 ◽  
Vol 49 (9) ◽  
pp. 820-825 ◽  
Author(s):  
Shino Karaki ◽  
Joji Mochida ◽  
Yoon Hwan Lee ◽  
Kazuhiro Nishimura ◽  
Yutaka Tsutsumi
Keyword(s):  
Low Grade ◽  
High Grade ◽  
Grade Malignancy ◽  
High Grade Malignancy

scholarly journals RESECTION OF ESOPHAGEAL GASTROINTESTINAL STROMAL TUMOR WITH HIGH-GRADE MALIGNANCY-A CASE REPORT-

2006 ◽  
Vol 67 (7) ◽  
pp. 1541-1545 ◽  
Author(s):  
Hisashi ISHIKURA ◽  
Hiroshi OKITSU ◽  
Akihiro SAKATA ◽  
Masashi ISHIKAWA ◽  
Jyunnichi SEIKE ◽  
...  
Keyword(s):  
Case Report ◽  
Gastrointestinal Stromal Tumor ◽  
Stromal Tumor ◽  
High Grade ◽  
Grade Malignancy ◽  
High Grade Malignancy

scholarly journals Dedifferentiated Acinic Cell Carcinoma of the Parotid Gland With Myoepithelial Features

2002 ◽  
Vol 126 (9) ◽  
pp. 1104-1105 ◽  
Author(s):  
Simonetta Piana ◽  
Alberto Cavazza ◽  
Corrado Pedroni ◽  
Rosa Scotti ◽  
Luigi Serra ◽  
...  
Keyword(s):  
Salivary Gland ◽  
Parotid Gland ◽  
Cell Carcinoma ◽  
Clinical Course ◽  
Acinic Cell Carcinoma ◽  
Low Grade ◽  
High Grade ◽  
Epithelial Proliferation ◽  
Acinic Cell

Abstract Dedifferentiated acinic cell carcinoma of the salivary gland is an uncommon variant of acinic cell carcinoma, characterized by the coexistence of both an usual low-grade acinic cell carcinoma and a high-grade dedifferentiated component, as well as by an accelerated clinical course. We describe a case of acinic cell carcinoma of the parotid gland in a 67-year-old woman, which recurred 4 times after surgery and radiotherapy. The recurrences consisted of residual foci of acinic cell carcinoma intermingled with a high-grade epithelial proliferation; the latter was focally constituted by cells with morphologic and immunohistochemical features of myoepithelium.

scholarly journals Musculoskeletal oncology: patient triage and management during the COVID-19 pandemic

2020 ◽  
Vol 27 (5) ◽  
Author(s):  
N. Olshinka ◽  
S. Mottard
Keyword(s):  
Surgical Oncology ◽  
Low Grade ◽  
High Grade ◽  
Oncology Patient ◽  
Exposure Risks ◽  
Grade Malignancy ◽  
Oncology Centre ◽  
Sarcoma Treatment ◽  
Musculoskeletal Oncology ◽  
High Grade Malignancy

Sarcoma treatment during the covid-19 pandemic is a new challenge. This patient population is often immunocom­promised and potentially more susceptible to viral complications.    Government guidelines highlight the need to minimize patient exposure to unnecessary hospital visits. However, those guidelines lack practical recommendations on ways to manage triage and diagnosis expressly for new cancer patients. Furthermore, there are no reports on the efficiency of the guidelines.    One of the main issues in treating musculoskeletal tumours is the complexity and variability of presentation. We offer a triage model, used in a quaternary-referral musculoskeletal oncology centre, that allows us to maintain an open pathway for referral of new patients while minimizing exposure risks. A multidisciplinary approach and analysis of existing investigations allow for a pre-clinic evaluation.    The model identifies 3 groups of patients: Patients with suspected high-grade malignancy, or benign cases with aggressive features, both in need of further evaluation in the clinic and prompt treatment Patients with low-grade malignancy, and benign cases whose treatment is not urgent, that are managed, during the pandemic by telemedicine, with reassurance and information about their illness Patients who can be managed by their local medical professionals    In comparison to a pre-pandemic period, that approach resulted in a higher ratio of malignant-to-benign con­ditions for new patients seen in the clinic (3:4 vs. 1:3 respectively), thus using available resources more efficiently and prioritizing patients with suspected high-grade malignancy.    We believe that this triage system could be applied in other surgical oncology fields during a pandemic.

L-TYPE AMINO ACID TRANSPORTER 1 EXPRESSION IN PROSTATE CANCER: ASSOCIATION WITH CANCER PROGRESSION AND HIGH-GRADE MALIGNANCY

2008 ◽  
Vol 179 (4S) ◽  
pp. 105-105
Author(s):  
Takefumi Satoh ◽  
Takeshi Sakata ◽  
Isao Okayasu ◽  
Golam Ferdous ◽  
Tomoko Tsuruta ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Amino Acid ◽  
Cancer Progression ◽  
Amino Acid Transporter ◽  
High Grade ◽  
Acid Transporter ◽  
Grade Malignancy ◽  
High Grade Malignancy
Sign in / Sign up

Export Citation Format

Share Document